BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2026)

BioNexus Gene Lab (BGLC) has 8 years of Inventory Average data on file, last reported at $671928.5 in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 47.66% year-over-year to $671928.5; the trailing twelve-month figure through Mar 2026 stood at $671928.5 (down 47.66% YoY), and the FY2025 full-year result was $1.0 million, down 18.25% from the prior year.
• Inventory Average eased to $671928.5 in Q1 2026, from $842075.5 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.6 million in Q1 2022 to a low of $671928.5 in Q1 2026.
• A 5-year average of $1.2 million and a median of $1.1 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average grew 23.69% in 2024 and plunged 47.66% in 2026, its largest moves.
• Tracing BGLC's Inventory Average over 5 years: stood at $1.0 million in 2022, then gained by 8.29% to $1.1 million in 2023, then gained by 23.69% to $1.4 million in 2024, then plunged by 39.37% to $842075.5 in 2025, then decreased by 20.21% to $671928.5 in 2026.
• Business Quant data shows BGLC's Inventory Average at $671928.5 in Q1 2026, $842075.5 in Q4 2025, and $1.1 million in Q3 2025.